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Abstract
Background: Many older people with neuropsychiatric disorders such as Alzheimer’s disease and frontotemporal
dementia suffer from sleeping problems and often show nocturnal restlessness. Professionals and informal carers
face considerable problems in solving these problems. Attempts to diminish these problems with medication in a
safe and responsible manner have proven hardly effective or not effective at all. Therefore, nowadays the focus lies
more on non-pharmacological solutions, for example by influencing environmental factors. There are indications
that treatment with low-frequency acoustic vibrations, that is Physio Acoustic Sound (PAS) therapy, has a positive
effect on sleeping problems. Therefore we study the effectiveness of PAS therapy in demented patients with
nocturnal restlessness.
Methods: In a randomized clinical trial, 66 nursing home patients will be divided into two groups: an intervention
group and a control group. For both groups nocturnal restlessness will be measured with actiwatches during a
period of six weeks. In addition, a sleep diary will be filled in.
For the intervention group the baseline will be assessed, in the first two weeks, reflecting the existing situation
regarding nocturnal restlessness. In the next two weeks, this group will sleep on a bed identical to their own, but
with a mattress containing an in-built PAS device. As soon as the patient is lying in bed, the computer programme
inducing the vibrations will be switched on for the duration of 30 min. In the last two weeks, the wash-out period,
the measurements of the intervention group are continued, without the PAS intervention.
During the total study period, other relevant data of all the implied patients will be recorded systematically and
continuously, for example patient characteristics (data from patient files), the type and seriousness of the dementia,
occurrence of neuropsychiatric symptoms during the research period, and the occurrence of intermittent co-
morbidity.
Discussion: If PAS therapy turns out to be effective, it can be of added value to the treatment of nocturnal
restlessness in demented patients. Non-pharmacological PAS therapy is not only safe and patient-friendly, but it
can also be widely used in a simple and relatively inexpensive way, both in institutions such as nursing homes and
residential homes for the elderly, and at home. Ultimately, this may lead to a decrease in the frequent and still
common use of psychotropic drugs. In addition, care needs of demented patients also may decrease as well as the
number of preventable admissions to care institutions.
Trial registration: Netherlands Trial Register (NTR): NTR3242
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Background
Many older people with neuropsychiatric disorders such
as Alzheimer’s disease [1] and frontotemporal dementia
[2] often suffer from sleeping problems, especially noc-
turnal restlessness. The concept of nocturnal restless-
ness can be described as a disturbance of the normal
sleeping pattern, manifesting itself in a certain way of
motor and/or verbal behavior. In general, nocturnal
restlessness should be placed in a wider context of beha-
vioral disorders, that are often associated with dementia
[3]. Common types of nocturnal restlessness include a
change or even a reversal of the day/night rhythm, high
motor activity levels during sleep, a frequent alteration
of sleeping phases and a frequent crying out and/or
wandering during the night. This disturbance of normal
sleep may lead to or coincide with serious inconveni-
ence and stress, not only for the patients themselves but
also for their informal carers, which is an especially
important reason to transfer (or admit early) a patient
to a nursing home [4].
Treatment of sleep disturbances in dementia
Nocturnal restlessness as well as other behavioral pro-
blems associated with dementia, are still mostly being
treated with psychotropic medication such as hypnotics
and antipsychotics in nursing homes as well as at home.
The results of such treatments are often disappointing
and negative side effects occur frequently. Research con-
ducted in nursing homes has even demonstrated that
this pharmacological approach has more adverse than
positive effects [5,6].
Adequate control of the day/night rhythm by influen-
cing lifestyle and environmental factors may sometimes
lead to better results [4-10]. This finding stimulates
further research on other, preferably non-pharmacologi-
cal treatment options for the problems of nocturnal
restlessness in dementia.
Effectiveness of Physio Acoustic Sound therapy
A new non-pharmacological treatment option was found
by chance by the staff of Zandhove, the central nursing
home of Zorgspectrum Het Zand in Zwolle, the Nether-
lands. It arose from the successful therapeutic applica-
tion of acoustic vibrations in order to reduce pain. This
Physio Acoustic Sound (PAS) therapy was originally
developed in Finland, where it has been used success-
fully for several decades, especially in patients with pain,
stress, and rigidity.
The therapy is based on practical experience as well as
research, both illustrating that low-frequency acoustic
vibrations (27-113 Hz) can have positive effects on sev-
eral symptoms. For instance, in an intervention period
of five weeks, PAS therapy has led to a decrease in self-
wounding, stereotype, and aggressive self-destructive
behavior in patients with autism and development disor-
ders [11]. Furthermore, a PAS therapy programme for
the elderly has proven to improve their general well-
being and functional capacity: bone formation and
mobility improved, cholesterol levels were lower, and
blood circulation was stimulated [12]. In another study,
PAS therapy caused patients to be more relaxed with
reduction of their pain symptoms [13,14]. The therapy
also has shown positive short-term effects on motor
symptoms in patients with Parkinson’s disease, for
example a decrease in rigidity, bradykinesia, tremor, and
an increase in step length [15].
Of the many observed effects of PAS therapy, the fol-
lowing have now been officially recognized by the
American Food and Drug Administration (Device Clas-
sification Name: vibrator, therapeutic; 510(k) nr.
K934886, reg. nr. 890.5975; d.d. 06-09-1994): relaxation,
reducing pain, and stimulating blood circulation.
Most of the results of PAS therapy have been obtained
by treatment in a so-called PAS therapy chair. The chair
contains acoustic equipment that generates a limited
range of low-frequency vibrations (27-113 Hz). Con-
trolled by computer programmes, these vibrations are
led through the chair in a wave sequence. The chairs
are now available in several countries, including the
Netherlands, and are used for several treatment pur-
poses [16].
PAS therapy in sleep disturbances in dementia
Many of the effects of PAS therapy mentioned above
have also been observed in daily practice in the nursing
home Zandhove of Zorgspectrum Het Zand. Moreover,
patients indicated that they were sleeping better after
treatment in the PAS therapy chair. To investigate
whether this particular effect also applies to demented
elderly people, for whom nocturnal restlessness is a
common cause of sleeping disorders, the same techni-
que as in the chair was recently built-in in mattresses.
These mattresses can be used on a standard high-




The aim of this study is to test, by means of a rando-
mized controlled trial, the hypothesis that application of
PAS therapy with low-frequency acoustic vibrations to
demented patients in nursing homes will lead to a sig-
nificant decrease of nocturnal restlessness.
Participants
The research population consists of demented nursing
home patients residing in one of the five psychogeriatric
nursing wards of Zorgspectrum Het Zand. Each ward
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has about 30 patients, who each have a single bedroom
and share a common living room (8 to 10 people).
Inclusion and exclusion criteria
Patients are included when diagnosed with the DSM-IV
definition of dementia and who have been residing in
the nursing home for a minimum of two months. Exclu-
sion criteria are (1) the presence of (high risk of) a pres-
sure sore, that is an indication for the preventive use of
a different mattress, for example an alternative mattress
to prevent pressure ulcers; (2) acute illness, for example
pneumonia, exacerbation of heart failure, a recent
stroke, and so on; and (3) a pacemaker, which could
possibly interfere with the PAS instruments.
Interventions
Patients will be randomized over an intervention group
and a control group. The patients in the control group
will sleep on their own high-dependency bed during the
three periods of two weeks each. The patients in the
intervention group will sleep, after the initial baseline
period of two weeks, on a high dependency bed identical
to their own for the second period of two weeks. The
mattress of this bed, however, contains the same techni-
que as the PAS therapy chair and will be controlled by
an external computer. As the intervention can be con-
trolled perfectly and safely via the computer regarding
frequency, duration and intensity, the technique is con-
sidered suitable for this research. In the third and last
(wash-out) period of two weeks they sleep again in their
own bed.
The computer programme controlling the acoustic
vibrations of the mattress will be switched on daily by
the nursing staff during a period of two weeks. This will
be done as soon as the patient is lying in bed. The pro-
gramme will switch off automatically after 30 min. So as
to not contaminate the results by the presence of the
staff, the staff member will leave the patient’s bedroom
as soon as the mattress is switched on. The frequencies
used in the programme lie between 27 and 40 Hz and
will vary every two or three minutes.
These frequency settings of the intervention have been
chosen after advice from Finnish professionals who have
many years of experience with this intervention. The
design of the programme used in this intervention was
originally aimed at reducing pain, and the varying fre-
quencies were based on Melzak and Wall’s gate control
theory [17].
The other therapeutic applications of PAS therapy
described above, whose effectiveness has already been
proven, are all based on this design as well.
Sample size
In this study, it is assumed that the nocturnal restless-
ness in patients in the control group will remain stable,
with a frequency of 80% episodes of nocturnal restless-
ness [18]. By applying PAS therapy, a conservative
decrease of nocturnal restlessness of 30% is expected,
resulting in a restlessness frequency of 50%. Taking into
account a probability value of 5% (alpha), a power of
80% (1-beta), and a drop-out rate of 10%, 66 patients
are needed in total, that is 33 in the intervention group
and 33 in the control group.
Randomization
By means of blinded block randomization with group
sizes of six, the randomization scheme will determine
which patients will be placed in the intervention group
and the control group. The intervention is not blinded
because it is visible for the caregiver (box with computer
below the bed and faintly audible (a very low buzz).
Procedure
After including the patients for participation in the
study, they will be divided into an intervention and con-
trol group by means of randomization. We have not
opted for a crossover design, as it cannot be estimated
how long the wash-out period will be [19]. For the sake
of the validity of the results to be obtained, a period of
six weeks (2 + 2 + 2) has been chosen for the interven-
tion group as well as for the control group. During this
total period, both groups of demented patients will con-
tinuously wear an actiwatch (respironics type AW2) on
the non-dominant wrist. Practice has shown that this
watch hardly causes any nuisance or no nuisance at all.
In addition, a daily sleep diary will be kept by the nur-
sing staff for all participants.
Figure 1 High-dependency bed with PAS mattress and night
table with computer which is normally locked up in the night
table.
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In the first two weeks, the baseline situation (T0) of
the intervention group and control group will be mea-
sured by means of the actiwatch. In the next two weeks,
as the intervention is executed in the intervention
group, in both groups the actiwatch measurements will
be continued (T1). In the last two weeks the wash-out
of the intervention will be measured and again in both
groups the actiwatch measurements will be continued
(T2).
During the whole period, the doors of the bedrooms
of all participants in both groups will remain closed dur-
ing the night, in order to prevent disruptions. Yet, if a
patient or staff member enters/leaves the room, this will
be noted in the sleep diary.
After the study period of six weeks, the actiwatches
will be read out. The collected data per patient will be
recorded, together with the other relevant data. These
include registered changes in the situation of the
patients during the study period, for example (1) possi-
ble additional co-morbid illness(es) that may lead to a
change in the level of motor restlessness or in the nor-
mal day/night pattern of the patient (for example pneu-
monia, delirium, urinary retention, constipation), or (2)
changes in the use of psychotropic drugs, therapies,
and/or use of restraints.
A schematic representation of the procedure can be
found in Table 1.
Data collection
First, the following patient characteristics will be col-
lected for both groups: age, gender, type of dementia,
co-morbidity (by means of CIRS [20]), incontinence Yes
or No, the use of restraints (for example fixation belts),
medication (including psychopharmacological drugs),
and other therapies.
In addition, the Bedford Alzheimer Nursing Severity
Scale (BANS-S) [21] will be applied by the psychologist
together with the nursing staff to get an impression of
the severity of dementia. This validated scale contains
seven items to assess functional and cognitive capacities
as well as pathological symptoms. These items, scaled 1
to 4, are summed. The overall score ranges from 7 (no
impairment) to 28 (complete impairment).
Although the traditional ‘gold standard’ assessing the
quality of the sleep is polysomnography (PSG), it is diffi-
cult to apply PSG to patients with a moderate to serious
form of dementia [22,23]. Therefore, in studies like this,
often more feasible assessment methods are used, like
observation-oriented techniques and actigraphy. Actigra-
phy is a less invasive method than PSG, offering a reli-
able way to estimate sleep/wake parameters including
nocturnal restlessness [24]. In this study we will use
both actigraphy and sleep diaries.
The nocturnal restlessness will be measured by vali-
dated actigraphy [25-27] in the intervention group as
well as in the control group on the basis of the follow-
ing sleep/wake parameters [28,29]: (1) nocturnal rest-
lessness: average motor activity during the night; (2)
sleep efficiency: the number of hours the patient is lying
in bed and actually sleeping; (3) wake bouts: the number
of episodes the patient is awake during the night; (4)
inter-daily stability: the degree of stability in activity pat-
terns over longer periods of time; (5) intra-daily variabil-
ity: the degree of inconstancy in rest and activity during
a day [28,29].
When considering nocturnal restlessness it is impor-
tant to take measurements during a period of at least two
weeks. In this way, the statistic power will increase [30].
To determine the degree to which the actimeters
respond to the acoustic vibrations of the mattress them-
selves, a control actimeter is placed on the mattress in
advance.
In addition, other relevant sleep observation data of
every patient will be written down in a sleep diary, in
which nocturnal restlessness and the day/night rhythm,
as observed by the nursing staff will be recorded.
Table 1 Measurements overview
Moment T0 Baseline T1 Baseline T2 Intervention T3 Intervention T4 Wash-out T5 Wash-out T6
Week 0 1 2 3 4 5 6
Actiwatch Continuous Continuous Charging Continuous Continuous Charging Continuous Continuous
NPI-Q T2 T4 T6
BANS-S T0
Patient characteristics T0
Sleep diary Continuous Continuous Continuous Continuous Continuous Continuous
Status examination T1 T2 T3 T4 T5 T6
T0, the week previous to the measuring period: complete BANS-S and make an inventory of patient characteristics (CIRS); T1, status examination; T2, end of
baseline period: complete NPI-Q and status examination; T3, status examination; T4, end of intervention period: complete NPI-Q and status examination; T5,
status examination; T6, end of wash-out period: complete NPI-Q and status examination. Actigraphy is taking place continuously. At T2 and T4, the actiwatch will
be charged for a short period (ca. 2 h).
A qualitative status examination will take place weekly (changes in medication, therapy, medical condition, means and measures, restlessness). The sleep diary
will be filled in daily during the whole measuring period.
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As shown in previous research, this ‘subjective’ infor-
mation will optimize the ‘objective’ information gained
by using the actimeters [31]. The nursing staff will
receive instructions on how to use the actiwatch, how to
fill in the sleep diary, and how to operate the computer.
Finally, it is important to carefully monitor the
changes in behavior of the participating demented resi-
dents, over the total study period. Therefore, a validated
Neuropsychiatric Inventory assessment (NPI-NH) [32]
will be performed in weeks 2, 4, and 6 by a psychologist
together with a nursing staff member who knows the
patient well. The NPI-NH contains 10 behavioral
aspects and two types of neuro-vegetative changes, that
is delusions, hallucinations, agitation, depression/dys-
phoria, anxiety, euphoria/elation, apathy/indifference,
disinhibition, irritability/lability, aberrant motor beha-
vior, night-time disturbances, and appetite/eating
change. This inventory will provide information on pos-
sible coexisting neuropsychiatric symptoms in patients
with Alzheimer disease or other dementia syndromes.
Both the frequency and severity of each symptom are
rated on a four- (1-4) and three-point (1-3) Likert scale,
respectively. A separate score can be calculated for each
symptom by multiplying the frequency and severity
scores, results ranging from 0 to 12 for each symptom.
A total score can be obtained by summing the 12 fre-
quency and severity scores, yielding total scores that
range from 0 to 144 [33].
Adverse effects
The study will be terminated if (1) the patient resists by
verbally and/or non-verbally putting up resistance when
using the intervention mattress and/or the actiwatch to
a higher degree than usual in situations deviating from
the daily routine; and (2) one of the previously men-
tioned exclusion criteria is met during the intervention
period.
As demented residents often cannot express their own
will themselves, the legal representative (mostly a family
member), together with the nursing staff, nursing home
physician, and/or psychologist, will assess whether resis-
tance to the intervention applies to the patient.
Approval
This study follows the Dutch Medical Research Involving
Human Subjects Act’s (WMO) and the Helsinki Declara-
tion’s principles, meaning that the (legal) representatives
of all demented patients will sign a written informed con-
sent, stating also that participation can be withdrawn at
any time, whenever the patient shows resistance, without
any negative consequences concerning their current or
future medical treatment. The Medical Ethical Commit-
tee of Maastricht University has granted ethical approval
(protocol 2011 nr. NL35287.068.11).
Statistical analysis
In order to process the data to test our hypothesis, the
statistical software programme SPSS-19 [34] will be
used. First, data will be checked for missing values and
normal distribution. It will be examined whether there
is a significant difference in both nocturnal restlessness
and degree of neuropsychiatric symptoms between the
intervention group and the control group.
To analyze the actigraphy variables and the variables
measured by means of NPI-NH (T0, T1, and T2) inte-
grally, a multilevel regression model (Mixed Models)
will be used. In this study, the Basic Two-Level Regres-
sion Model [35] will be used, in which the actigraphy
variables and NPI-NH variables are the lowest levels
(that is dependent variable) and the research partici-
pants the highest level (independent variable).
The multilevel analysis enables us to calculate the
degree of nocturnal restlessness and neuropsychiatric
symptoms despite the unequal number of observations
per individual (missing values/dropouts). This means
that all data will be included in the analysis, including
the data of participants who will meet stop criteria dur-
ing the investigation and for whom the study has to be
terminated early.
If there is interaction effect between time and group, a
post-hoc analysis will be performed, taking into account
that T0-T1 indicates PAS therapy effects and that T1-
T2 indicates the long-term effects of PAS therapy. The
analyses will be corrected for basic differences in the
characteristics of the patients belonging to the interven-
tion group and the control group respectively. The data
in the sleep diaries will first be coded and later analyzed
separately by means of describing statistics.
Primary outcome measures
The objectively and subjectively measured difference in
nocturnal restlessness between T0-T1-T2. Objectively,
the nocturnal restlessness measured during six weeks by
means of an actiwatch validated for sleep research with
the sleep/wake parameters mentioned above.
Subjectively, nocturnal restlessness determined on the
basis of a sleep diary developed for this study, and filled
in by the nursing staff.
Secondary outcome measures
The secondary outcome measure in this study involves
an analysis of the prevalence and the degree of change
in overall neuropsychiatric symptoms of the nursing
home patients taking part in the study.
Discussion
In general, professionals and informal caregivers often
face considerable difficulties in solving behavioral pro-
blems present in demented people. In this study we
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focus on the problem of nocturnal restlessness, often
leading to a diminished quality of life of the patients
involved, and sometimes a severe burden for the
patient’s environment. Attempts to solve this problem
adequately and safe with medication have proven to be
hardly effective or not effective at all [5].
That is the most important and underlying reason for
research on the effectiveness of non-pharmacological
interventions. This study about the effectiveness of the
PAS therapy, a non-pharmacological treatment option
for nocturnal restlessness in demented people, is an
example of this type of studies. PAS therapy is safe and
patient-friendly and has not led to undesired side effects
or reports of adverse effects in other applications.
The design chosen for this study has some limitations.
For instance, it is not possible to carry out a double-
blinded study, as the PAS mattress involves a light buzz-
ing and is controlled by a computer that is built in the
night table next to the bed.
However, given the setting and the nature of the
group of residents, the risk of contamination can be
considered to be small.
Furthermore, actigraphy is particularly suitable for
measuring nocturnal restlessness, but less suitable for
measuring periods during which the patient lies awake
quietly [27].
In addition, it must be noted that when it comes to
writing down data in the sleep diaries, the researchers
depend on the nursing staff’s compliance. Therefore, the
nursing staff has received explicit instructions, and the
researchers regularly check whether these instructions
are being followed. Nevertheless, in daily practice of
nursing home care, it is impossible to completely take
into account all relevant factors.
Despite these limitations, if proven effective, this form
of PAS therapy can be widely introduced in a simple and
relatively inexpensive manner in order to reduce noctur-
nal restlessness in demented people. The therapy can be
applied in institutions, for example nursing homes and
residential homes for the elderly, as well as at home.
Ultimately, this may lead to a decrease in the frequent
and still common use of often harmful psychotropic
drugs.
In a more general sense, the care needs of demented
people may decrease as well as the number of preventa-
ble admissions to care institutions [36].
Trial status
The study started recruiting participants in July 2011.
This is still ongoing. Soon after the first recruitments,
the interventions and the measurements started as well.
We expect the results to be published at the end of
2013.
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